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          The thesis entitled “Total synthesis of anticancer natural cyclic tetrapeptide 
Azumamide E, Aminoxy peptide oligomers and PEG as solvent medium for 
hydrogenation” is divided into three chapters. 
CHAPTER-I: Chapter I describes the introduction to histone deacetylase (HDAC) 
inhibitors and total synthesis of Azumamide E. 
CHAPTER-II: Chapter II describes the introduction to peptidomimetic foldamers and 
synthesis of the oligomers of cis-β2,3-furanoid sugar aminoxy acid.  
CHAPTER-III: This chapter deals with the introduction to poly (ethylene glycol) and 
catalytic hydrogenation with PtO2 in poly (ethylene glycol) (400).  
 
CHAPTER-I: Introduction to histone deacetylase (HDAC) inhibitors and total 
synthesis of Azumamide E. 
Histone deacetylases (HDACs) are eukaryotic enzymes that, interfering with post 
translational chromatin modification, apoptosis and angiogenesis. Histone deacetylases 
modulate chromatin structure and function by deacetylating the ε-N-acetyl lysine residues 
on proteins, including histones. Inhibitors of HDACs induce cell differentiation and 
suppress cell proliferation in tumor cells. HDAC inhibitors have become promising 
anticancer agents in recent years. A wide range of structures have been shown to inhibit 
the activity of HDAC enzymes, and with few exceptions, these can be divided into 
structural classes including small-molecule hydroxamates, carboxylates, benzamides, 
electrophilic ketones, and cyclic peptides.  
          Fusetani and co-workers reported the isolation, structure elucidation, and biological 
activities of five new cyclic tetrapeptides azumamides A-E from the marine sponge  
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Mycale izuensis. The basic structural motif of the azumamides (Table 1) consists of a 13-
membered cyclic tetrapeptide core, three of which are α-amino acids belongs to the D- 
series while the fourth one is a unique β- amino acid. Azumamide E (1) is the most 
powerful carboxylic acid containing natural histone deacetylase (HDAC) inhibitor (IC50 = 
0.064 µM). 
 
 
 
 
 
 
 
 
 
 
 
           As a continuation of our studies on the synthesis of structurally novel and 
challenging natural products, we have attempted the total synthesis of azumamide E. This 
chapter describes the total synthesis of azumamide E (1).         
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          Retrosynthetic analysis of azumamide E (1) is shown in scheme 1. First 
azumamide E was disconnected at the amide bond between D-valine and β-amino acid 
segment. Tetrapeptide 2 could be elaborated from trimer 4 and β-amino ester 3. The β-
amino ester 3 in turn could be obtained form butyne 1, 4 diol 5 and 4-pentyn-l-ol 6.  
 
 
 
 
 
 
          
         The butyne 1, 4 diol 5 was treated with SOCl2 and pyridine to give the 
chlorobutynol 7 (scheme 2). The hydroxyl group in 4-pentyn-l-ol 6 was protected as its 
MPM ether 8 by treatment with NaH, MPM Cl and TBAI. The chloro butyne-1-ol 7 was 
coupled with 8 in presence of CuI, NaI and K2CO3 to generate the skipped diyne 9. The 
selective reduction of propargylic alcohol functionality to (E) - allyl alcohol 10 was 
achieved by LiAlH4 as reducing agent. The resulting allyl alcohol was subjected to 
asymmetric epoxidation with L-(+) -diethyl tartrate, Ti (OiPr)
 4 and TBHP to give epoxy 
alcohol 11 (scheme 3). 
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        The epoxy alcohol 11 was subjected to two step oxidation followed by esterfication 
to furnish the epoxy ester 12. In the epoxy ester 12 the epoxide functionality was 
regioselectively opened with lithium dimethyl cuprate to afford β-hydroxy ester 13 via 
ring opening at C-2. The catalytic hydrogenation of 13 in the presence of Lindlar catalyst 
and quinoline gave Z-olefinic product 14. The Mitsunobu inversion of the free 2° alcohol 
of 14 using diphenyl phosphoryl azide (DPPA) provided the azide 15. The azide 15 was 
subjected to Staudinger reaction with TPP in THF: H2O (9:1) to furnish the β-amino acid 
methyl ester 3 (scheme 4). This is a key intermediate in the total synthesis of azumamide 
E. 
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D-alanine 16 was treated with acetyl chloride in methanol to furnish the methyl 
ester and the amine functionality was protected as Boc-derivative [Boc-(DAla)-OCH3] 17 
using (Boc)
 2O and Et3N in THF. Hydrolysis of 17 with LiOH.H2O in THF: H2O (8:2) 
furnished acid 18 and used as such for next reaction (scheme 5). 
 
 
 
 
 
 
 
 
           D-Valine 19 was treated with acetyl chloride in methanol followed by (Boc)2O 
and Et3N gave the [Boc-(DVal)-OCH3] 20. Hydrolysis of 20 with LiOH.H2O in THF: 
H2O (8:2) furnished the acid 21 and used as such for next reaction (scheme 6). 
The D-N-Boc alanine 18 was coupled with the methyl ester of phenyl alanine 22 
under EDCI/HOBt conditions to get the dipeptide 23. In dipeptide 23 NH-Boc was 
deprotected with TFA in dry CH2Cl2 to afford amine salt, which was coupled with N-
Boc-D-Valine 23 under standard coupling conditions with EDCI/HOBt and DIPEA to 
furnish tripeptide 24. The tripeptide 24 which on LiOH hydrolysis gave acid 4, which was 
used as it is for the next reaction (scheme 7). 
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The coupling of Boc protected tripeptide acid 4 and amine 3 under standard 
coupling conditions in the presence of EDCI and HOBt gave tetrapeptide 2, which was 
further reacted with TBSOTf and 2, 6-lutidine as base to furnish silyl carbamate. This on 
LiOH mediated double hydrolysis of silylcarbamate and methyl ester functionalities 
provided free amino acid 25 in 81% yield, which was ready for the macrolactamization. 
The cyclization of tetra amino acid 25 was attempted with EDCI and HOBt under high 
dilution condition to successfully obtain the protected azumamide 26 in 79% yield. The  
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cleavage of MPM ether under oxidative conditions (DDQ, CH2Cl2:H2O) provided the 
free alcohol 27 which on further oxidation with BAIB, TEMPO resulted in the efficient 
total synthesis of the target compound 1 in over 84% yield (scheme 8). 
         In summary, the synthesis of azumamide E 1 involving solution phase peptide 
synthesis strategy was successfully achieved using Sharpless asymmetric epoxidation, 
regioselective opening of epoxide and macrolactamization as key steps in good overall 
yields.  
 
CHAPTER-II: Chapter II describes the introduction to peptidomimetic foldamers 
and synthesis of the oligomers of cis-β2,3-furanoid sugar aminoxy acid.  
         
          The search for new foldamers, oligomers with rigid and predictable secondary 
structures, has been an interesting area of research. Thus, many bioorganic and synthetic 
chemists have made attempts in these areas to prepare structurally well defined and/or 
biologically active peptidomimetics with novel backbone structures for the creation of 
new secondary and tertiary structures. As a result a number of backbone modified 
peptides have been synthesized and characterized for their novel structures and/or 
biological functions. The backbone modification includes chain extension or heteroatom 
incorporation. 
          Aminoxy peptides are oligomers of aminoxy acids. Aminoxy acids are unnatural 
amino acids with an oxygen atom inserted between the amino group and the 
neighbouring carbon atom of amino acids. The α−Aminoxy acid is an oxa analog of 
β−amino acid in which the β-carbon is replaced by an oxygen atom, and β−aminoxy acid 
is an oxa analog of γ−amino acid in which the γ-carbon is replaced by an oxygen atom. 
Due to the lone-pair electronic repulsion between nitrogen and oxygen atoms, aminoxy 
acids have more rigid backbone than normal amino acids. Because of the high 
electronegativity of the inserted oxygen atom, the acidity of the protons on aminoxy 
amides is higher than that of protons on normal amides. As a result, aminoxy amide 
protons, compared to normal amide protons, can form stronger intramolecular hydrogen 
bonds with oxygen atoms of other amide carbonyls. Peptides consisting of α -aminoxy  
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acids can possess eight-membered-ring intramolecular hydrogen bonds (α N-O turns) and 
peptides consisting of β -aminoxy acids can possess nine membered-ring intramolecular 
hydrogen bonds (β N-O turns). 
        To enrich the category of aminoxy peptides and to test the ability of other aminoxy 
peptides to form local intramolecular hydrogen bonds, we sought to synthesize cis-β2,3-
furanoid sugar aminoxy acid and its oligomers. 
Synthesis of cis-β2,3-furanoid sugar aminoxy acid: 
        The synthesis of cis-β2,3-furanoid sugar aminoxy acid (cis-f-SAOA) was started 
from commercially available D-glucose 1. It was protected as its diacetonide using conc. 
H2SO4 (catalytic) and CuSO4 in acetone. Inversion of configuration at C-3 position in 
glucose diacetonide 2 was carried out by oxidation with PDC (pyridinium dichromate) 
followed by reduction using NaBH4/MeOH. The inverted hydroxy group in 3 was 
converted to a phthaloyl aminoxy group under Mitsunobu conditions with triphenyl 
phosphine (PPh3), diisopropyl azodicarboxylate (DIAD) and N-hydroxy pthalimide in  
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anhydrous THF. The exocyclic hydroxylic groups in compound 4 are selectively 
deprotected to diol 5 using 0.8% H2SO4 solution (aqueous) in methanol. The diol 5 is 
oxidatively cleaved by using NaIO4 in THF and H2O. The aldehyde 6 on treatment with 
NaClO2, NaH2PO4 and H2O2 in CH3CN: H2O gave sugar aminoxy acid 7 (scheme 1).  
      Sugar aminoxy acid 7 was coupled with isobutyl amine using EDCI and HOBt in 
CH2Cl2 and DMF to furnish the diamide 8. Deprotection of the phthaloyl group in 
diamide 8 using hydrazine hydrate in methanol and CH2Cl2 gave the free amine 9, which 
was subsequently coupled with Piv-Cl in the presence of 10% NaHCO3 to provide the 
diamide 10 (scheme 2).   
 
 
 
 
 
 
 
 
 
 
Syntheses of oligomers of cis-β2,3 -furanoid sugar aminoxy acid: 
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Oligomers of cis-β2,3 -furanoid sugar aminoxy acid were prepared using the 
monomers 7 and 9. Monomers 7 and 9 coupled with EDCI and HOBt provided triamide 
11. Same set of reactions was carried out for phthaloyl group deprotection and pivoloyl 
protection which provided triamide 13 (scheme 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Monomer acid 7 and aminoxy amine 12 were coupled with EDCI and HOBt in 
CH2Cl2 and DMF gave tetraamide 14. Same set of reactions was carried out for phthaloyl 
group deprotection and pivoloyl protection which provides tetraamide 16 (scheme 4). 
          In summary, new class of cis-β2,3-furanoid sugar aminoxy acid oligomers was 
synthesized and characterized by NMR, CD and molecular dynamics. These novel 
peptidomimetics comprised of carbohydrate backbone, have exhibited unique 
conformational preference of forming ribbon like structures favoring 5/7 bifurcated 
intramolecular hydrogen bonded rings which have not been observed in β-aminoxy 
peptides earlier.  
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CHAPTER-III: This chapter deals with the introduction to poly (ethylene glycol) 
and catalytic hydrogenation with PtO2 in poly (ethylene glycol) (400).  
          Traditionally catalytic reactions are performed in volatile organic solvents 
(VOCs), but there are some disadvantages associated with those solvents that can be 
avoided by using nonvolatile organic liquids. The development of alternative greener 
solvents for catalytic reactions continued to attract the attention. Alternative solvents 
have been the subject of much research in recent years including studies of supercritical 
CO2, near critical water, ionic liquids, and fluorous based systems. Recently, poly 
(ethylene glycol) (PEG) is found to be an interesting solvent system. The important 
difference between using PEG and other neoteric solvents is that all of the toxicological 
properties, the short and long-term hazards, and the biodegradability, etc., are established 
and known. PEGs are preferred over other polymers because they are inexpensive and 
completely nonhalogenated. PEG as environmentally benign protocol proved to have 
many applications particularly, in substitution, oxidation, and reduction reactions. 
Another advantage of PEG is the efficient separation of catalysts and reagents to enable 
their reuse for subsequent cycles of reactions. 
          An ambitious exercise has been taken up to develop poly (ethylene glycol) (400) as 
recyclable solvent medium for Adams’ catalyst (PtO2), one of the most expensive metal 
catalysts that richly deserves recyclability. 
Catalytic hydrogenation with PtO2 in poly (ethylene glycol) (400). 
        Adams' catalyst, also known as platinum dioxide, is usually represented as 
platinum(IV) oxide hydrate, PtO2-H2O. Adams’ catalyst in poly (ethylene glycol) (PEG) 
(400) has been found to be a superior solvent over the ionic liquids by several fold in 
promoting the hydrogenation of various functional groups (Olefins, -NO2, -N3) (scheme 1 
and 2). Both the catalyst and PEG were recycled and reused efficiently over 10 runs  
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without loss of activity, and substrate cross contamination was not observed despite a 
change in the substrate for four times. 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Catalytic hydrogenation in PEG(400) using PtO2 .
Entry Substrate Product Timea (h) Yieldb (%)
1
2
3
2
9
93
92
aTime in hours bAll the products were characterised by 1H, 13C NMR, IR and Mass spectra
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        In the first instance, cinnamyl alcohol 1a (entry 1, Table 1) was subjected to PtO2-
catalyzed hydrogenation at atmospheric pressure with the aid of a balloon to observe 
clean formation of 3-phenyl-n-propanol 1b in less than 3 h. Similarly, ethyl-4-
methoxycinnamate 10a (entry 2, Table 2) was subjected to hydrogenation with 5 mol % 
PtO2 in PEG (400 Da) for 2 h to isolate the saturated ester 10b in greater than 93% yield 
and greater than 95% purity just by ethereal workup (vide infra). The same substrate 
(entry 2, Table 2) when subjected to hydrogenation in ionic liquid (EMIMBF4) was 
resistant even after 24 h (15% conversion). Two other substrates, namely the carvone 9a 
(entry 1, Table 2) and the sugar derivative 11a (entry 3, Table 2), having a hydrogenation 
sensitive benzyl ether were effectively saturated in greater than 90% yields in PEG. The 
benzyl ether cleavage was not observed even in traces. These two substrates when 
subjected to PtO2 catalyzed hydrogenation in ionic liquid (EMIMBF4) yielded products in 
poor conversion and yields (entries 2 and 3, Table 2). To understand more closely the 
chemisorption of Adams’catalyst in PEG over ionic liquids, quantitative adsorption of 
hydrogen on PtO2 in both solvents was taken up. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Comparision of catalytic hydrogenation in PEG and IL using PtO2
Entry Substrate Product
In PEG
Timea 
   (h)
Yieldb 
   (%)
O O
MeO
COOEt
MeO
COOEt
O
O
O
BnO
C3H7
1
2
3
3
2
4
97
93
94
23
24
25
40
15
20
aTime in hours bAll the products were characterised by 1H, 13C NMR, IR and Mass spectra
In IL
Timea 
   (h)
Yieldb 
   (%)
O
O
O
BnO
C3H7
9a 9b
10a 10b
11a 11b
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          The pulse chemisorption of H2 was employed to know the amount of H2 
chemisorbed on PtO2 (catalyst) in the presence of solvent (PEG/IL). The pretreatment of 
catalyst was performed by passing N2 at ambient temperature for 1 h. Then the hydrogen 
was chemisorbed on pretreated catalyst at room temperature in pulses through a six-port 
valve. In a typical experiment, 10 mg of the catalyst in 1 mL of PEG/IL was taken in a 5-
mL round bottom flask. The outlet of the reactor was connected to a microthermal 
conductivity detector (TCD) equipped with GC-17A (M/S Shimadzu Instruments, Japan) 
through a blank column. After the pretreatment of the catalyst, pulses of H2 (purity 
99.99%) were injected at room temperature through a 500-µL loop connected to the six-
port valve until no further change in the intensity of the outlet H2 (monitored by a data 
station with CLASS 10 GC software) was observed. The cumulative H2 consumption was 
recorded against five pulses, and the data recorded (Figure 1) clearly demonstrated that 
the H2 adsorption into PtO2 in PEG is several fold superior to ionic liquid. This is direct 
evidence for the efficient reduction of functional groups in PEG over the ionic liquids. 
 
 
 
 
 
 
 
 
 
 
 
 
          In conclusion, the very expensive PtO2 has been recycled several times in PEG 
(400) without considerable loss of activity. Also, dissolution of H2 in PEG and ionic 
liquid was studied using a gas chromatography technique to prove the fact that the H2 
dissolution plays an advantageous role in favor of PEG over ionic liquid.  
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